These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5616009)

  • 1. [Effects of new vasoactive drug, 3(beta-diethylamino-ethyl)-4-methyl-7-(carbethoxy-methoxy)-2-oxy-1,2-chromen HC1 (Intensain) on the coronary circulation in dogs].
    Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Minerva Cardioangiol; 1967 Nov; 15(11):722-4. PubMed ID: 5616009
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG; Terry W; Stenlund RR; Thomsen JH; Querimit AS
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):99-103. PubMed ID: 5353477
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG; McKenna DH; Sialer S; Corliss RJ
    Vasc Dis; 1967 Jun; 4(3):183-90. PubMed ID: 6028828
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacodynamic effect on coronary blood circulation and metabolism of the human heart. Studies with 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromen)-hydrochloride].
    Rudolph W; Meixner L; Künzig HJ
    Klin Wochenschr; 1967 Apr; 45(7):333-53. PubMed ID: 5585313
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Intensain, a coronary dilator, on hemodynamics and its application for general anesthesia].
    Saito T; Okazaki K; Hirano T; Matsuzaki T; Wakizaka K
    Masui; 1966 Mar; 15(3):251-7. PubMed ID: 6007412
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilator effects of verapamil and propafenon].
    Mill JG; Vassallo DV; Futuro Netto HA
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():7-10. PubMed ID: 678166
    [No Abstract]   [Full Text] [Related]  

  • 7. A new vasoactive substance regulating the metabolic response of the coronaries.
    Szentiványi M; Juhász-Nagy A; Debreczeni L
    Acta Physiol Acad Sci Hung; 1967; 31(1):9-32. PubMed ID: 6079690
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
    Sano N; Katsuki S; Kawada M
    Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine.
    Shen YT; Vatner SF
    J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective vasodilatory effect of dipfluzine on vertebral artery in anesthetized dogs.
    Wang YL; He RR
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):124-7. PubMed ID: 8352003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of a beta-adrenergic-blocking agent (propranolol) on systemic and coronary hemodynamics in dogs].
    Feruglio FS; Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Boll Soc Ital Biol Sper; 1966 Sep; 42(18):1209-11. PubMed ID: 5971146
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of diphenylhydantoin on coronary and systemic haemodynamics in awake dogs.
    Zeft HJ; Rembert JC; Curry CL; Greenfield JC
    Cardiovasc Res; 1973 May; 7(3):331-5. PubMed ID: 4722930
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of pharmacologic agents coronary circulation in experimental spasms of heart vessels].
    Kareva GF
    Vestn Akad Med Nauk SSSR; 1963; 18(1):28-32. PubMed ID: 4971961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical pharmacological studies of the coronary dilator 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride. 1. Methods for determination of the substance and its metabolites in plasma, tissues and urine].
    Klarwein M; Nitz RE
    Arzneimittelforschung; 1965 May; 15(5):555-8. PubMed ID: 5898299
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluorinated organic compounds with potential biological activity. VII. (1) N-substituted amides of alpha-fluoroarylacetic acid].
    Cavalleri B; Sardi A
    Farmaco Sci; 1970 Nov; 25(11):809-21. PubMed ID: 5491961
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of prostaglandin A 1 on cardiovascular dynamics and myocardial metabolism.
    Barner HB; Kaiser GC; Hahn JW; Jellinek M; Amako H; Lee JB; Willman VL
    J Surg Res; 1972 Mar; 12(3):168-72. PubMed ID: 5020462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Selective influencing of the myocardial blood supply in dogs using drugs].
    Hapke HJ
    Dtsch Tierarztl Wochenschr (1946); 1969 Oct; 76(19):518-21. PubMed ID: 5355903
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of batroxobin on coronary segmental resistance and coronary blood flow in acute myocardial ischemic dogs].
    Gao F; Sun CK; Pei JM; Wang YM; Li Y; Niu GB; Zang YM
    Yao Xue Xue Bao; 1996; 31(10):727-31. PubMed ID: 9863238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of NO release in the control of large and small coronary artery tone in conscious dogs.
    La Rochelle CD; Dubois-Randé JL; Richard V; Hittinger L; Giudicelli JF; Berdeaux A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S17-21. PubMed ID: 7504763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.